Covishield vaccine, is expecting to launch another vaccine, Covavax, in the country by September, news agency ANI reported, citing sources.
Covavax is a version of US firm Novavax's COVID19 vaccine candidate. The clinical trials of Covavax are in an advanced stage of completion in India.Earlier this week, Novavax Inc, which has a vaccine manufacturing agreement with Serum Institute of India, said its COVID-19 vaccine candidate was highly effective with 90.4% efficacy overall and also showed high efficacy against predominantly circulating variants.